These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6538102)

  • 1. Urinary androgen and 17-hydroxylated corticosteroid metabolites and their relation to recurrence rates in early breast cancer.
    Thomas BS; Bulbrook RD; Russell MJ; Hayward JL; Millis RR
    Breast Cancer Res Treat; 1984; 4(1):27-35. PubMed ID: 6538102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of urinary androgen metabolites to breast diseases including carcinoma.
    Wetchler BB; McCarrick J; Allerhand J; Dreiling DA
    Mt Sinai J Med; 1974; 41(5):682-6. PubMed ID: 4278335
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary androgen metabolites and recurrence rates in early breast cancer.
    Thomas BS; Bulbrook RD; Hayward JL; Millis RR
    Eur J Cancer Clin Oncol; 1982 May; 18(5):447-51. PubMed ID: 6889522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary steroid excretion pattern in diabetes mellitus.
    Charro-Salgado AL; Clarke BF; Shackleton CH; Duncan LJ; Mitchell FL
    Lancet; 1968 Jan; 1(7534):126-7. PubMed ID: 4169704
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary androgen excretion and the etiology of breast cancer.
    Bulbrook RD
    J Natl Cancer Inst; 1972 Apr; 48(4):1039-42. PubMed ID: 5023673
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of thyroid funtion and of obesity on discriminant function for mammary carcinoma.
    Sneddon A; Steel JM; Strong JA
    Lancet; 1968 Oct; 2(7574):892-4. PubMed ID: 4176150
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary and plasma androgens and their relation to familial risk of breast cancer.
    Wang DY; Bulbrook RD; Hayward JL
    Eur J Cancer (1965); 1975 Dec; 11(12):873-7. PubMed ID: 130241
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormal urinary steroid excretion and subsequent breast cancer. A prospective study in the Island of Guernsey.
    Bulbrook RD; Hayward JL
    Lancet; 1967 Mar; 1(7489):519-22. PubMed ID: 4163897
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormonal status of breast cancer. II. Abnormal urinary steroid excretion.
    Kodama M; Kodama T; Yoshida M; Totania R; Aoki K
    J Natl Cancer Inst; 1975 Jun; 54(6):1275-82. PubMed ID: 1133844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign and malignant breast disease in South Wales: a study of urinary steroids.
    Cameron EH; Griffiths K; Gleave E; Stewart HJ; Forrest AP; Campbell H
    Br Med J; 1970 Dec; 4(5738):768-71. PubMed ID: 4250592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of response to adrenalectomy in the treatment of advanced breast cancer.
    Masnyk IJ; Silverman DT; Hankey BF
    J Natl Cancer Inst; 1978 Feb; 60(2):271-8. PubMed ID: 621745
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone examination in children with Klinefelter's syndrome].
    Gleispach H; Glatzl J
    Wien Klin Wochenschr; 1969 Nov; 81(45):811-5. PubMed ID: 4311975
    [No Abstract]   [Full Text] [Related]  

  • 13. Tryptophan metabolism in breast cancer. Correlation with urinary steroid excretion.
    Davis HL; Brown RR; Leklem J; Carlson IH
    Cancer; 1973 May; 31(5):1061-4. PubMed ID: 4705147
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyroid function in early breast cancer.
    Thomas BS; Bulbrook RD; Russell MJ; Hayward JL; Millis R
    Eur J Cancer Clin Oncol; 1983 Sep; 19(9):1213-9. PubMed ID: 6684568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary and plasma androgens in benign breast disease. Possible relation to breast cancer.
    Brennan MJ; Wang DY; Hayward JL; Bulbrook RD; Deshpande N
    Lancet; 1973 May; 1(7812):1076-9. PubMed ID: 4122007
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of urinary 17-hydroxycorticosteroid and 11-deoxy-17-oxosteroid excretion in obesity, in thyroid dysfunction and in early breast cancer.
    Sneddon A; Steel JM; Strong JA
    J Endocrinol; 1969 Feb; 43(2):48-9. PubMed ID: 4237784
    [No Abstract]   [Full Text] [Related]  

  • 17. Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone.
    BULBROOK RD; GREENWOOD FC; HAYWARD JL
    Lancet; 1960 May; 1(7135):1154-7. PubMed ID: 13805841
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary steroids in breast cancer.
    Nature; 1969 Jan; 221(5177):218. PubMed ID: 5763075
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship of urinary and plasma androgens to steroid receptors and menopausal status in breast cancer patients and their influence on survival.
    Mason BH; Holdaway IM; Skinner SJ; Kay RG
    Breast Cancer Res Treat; 1994; 32(2):203-12. PubMed ID: 7865850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discriminant function in early carcinoma of the breast.
    Wade AP; Tweedie MC; Davis JC; Clarke CA; Haggart B
    Lancet; 1969 Apr; 1(7600):853-7. PubMed ID: 4180521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.